Can a quick chat in the Doctor's office prevent youth overdoses?
NCT ID NCT07022717
First seen Jun 26, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This pilot study tests whether a brief overdose prevention education, including naloxone training, is feasible and acceptable for youth ages 13-26 during routine primary care visits. Providers will deliver the intervention to some youth, while others receive usual care. The study aims to see if this approach can be implemented in real-world clinics and whether youth find it helpful.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Brief overdose prevention education and naloxone information
What this could lead to
If successful, this could lead to a scalable, evidence-based overdose prevention program for youth in primary care settings.
What could go wrong
This is a very small pilot study (24 participants) focused on feasibility, not effectiveness. It may not show a reduction in overdose rates or be generalizable beyond this single center.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERDOSE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Boston Medical Center, Pediatric Primary Care & Family Medicine
RECRUITINGBoston, Massachusetts, 02118, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••